Executive Leadership Replimune recently appointed Sushil Patel, Ph.D., as the new CEO and Madhavan Balachandran to its Board of Directors, showcasing a reinvigorated leadership team that may present opportunities for partnership discussions.
Funding & Expansion Having secured approximately $100 million in financing through a PIPE deal, Replimune is in a strong financial position for growth and potential collaborations, making it an attractive target for business development initiatives.
Product Launch Replimune's launch of its lead product candidate, RP1, signals an exciting milestone that could drive market interest, presenting sales opportunities for strategic partnerships or investor engagement.
Experienced CFO With the recent appointment of Emily Hill as Chief Financial Officer, Replimune has strengthened its financial leadership, potentially fostering investor confidence and creating avenues for financial collaborations.
Market Position Positioned among peers like Transgene, OSE Immunotherapeutics, and 4D Molecular Therapeutics, Replimune's revenue range and innovative therapies make it a compelling player for potential market collaborations or competitive positioning strategies.
209
$50M$100M
41K$1B
69$10M$50M
222$10M$50M
91$10M$50M
36K$1BReplimune uses 8 technology products and services including SAS/GRAPH, Veeva Vault, Modernizr, and more. Explore Replimune's tech stack below.
| Replimune Email Formats | Percentage |
| First.Last@replimune.com | 91% |
| First@replimune.com | 5% |
| FirstLast@replimune.com | 3% |
| FirstL@replimune.com | 1% |
Biotechnology ResearchMassachusetts, United States201-500 Employees
Replimune's mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response. Replimune is pioneering the development of novel oncolytic immunotherapies. We imagine a world where cancer is a curable disease.
Company Overview
Media & News
Funding & FinancialsReplimune has raised a total of $155M of funding over 2 rounds. .
Replimune's revenue is in the range of $10M$50M
Funding & FinancialsReplimune has raised a total of $155M of funding over 2 rounds. .
Replimune's revenue is in the range of $10M$50M
1-888-653-2347 
support@leadiq.com